This meeting took place in 2003



For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

New Advances in Drug Discovery (A3)


Organizer(s) James A. Wells and Robert F.G. Booth
January 7—12, 2003
Yarrow Resort Hotel • Park City, Utah USA
Abstract Deadline: Sep 16, 2002
Late Abstract Deadline:
Scholarship Deadline:
Early Registration Deadline: Nov 7, 2002

Sponsored by ICOS Corporation

Summary of Meeting:
The Keystone Meeting on New Advances in Drug Discovery is held every other year and is intended to capture the most exciting developments in Industry and Academia related to Drug Discovery. The meeting has traditionally been one of the most dynamic Keystone conferences because of the cross-section of scientists that are assembled to discuss key advances in biopharmaceutical sciences. There are now many opportunities to enhance drug discovery through the utilization of data from the Human Genome Project and through new tools designed to exploit the information. In addition, a variety of novel technologies are emerging which promise to enhance the productivity of drug discovery. All of this is fueled by the need to improve the efficiency of drug discovery. It is the objective of this meeting to focus on the most exciting new technologies, trends and potential success stories in novel areas of drug discovery. Rather than providing broad reviews of general fields or company overviews, the meeting is intended to provide new scientific achievements in the area of biomedical and pharmaceutical research. The meeting will include new breakthroughs in the following areas: New approaches to the discovery of small molecules The impact of genomics and proteomics to drug discovery Emerging target classes New drug candidates In the first part of the meeting the focus will be on the ways in which structural, computational and combinatorial approaches have improved our ability to design small molecules, both in terms of speed and quality. The session on genomics will provide information on the latest advances in these fields and their impact on our understanding of the biology emerging from the human genome project. The ability of these technologies to aid in the identification of attractive new drug targets will be assessed. The majority of small molecule drugs reaching the market have focused on a very limited set of target classes (GPCRs, proteases etc). The third session will focus on newly emerging target classes and the progress that is being made to bring molecules from these classes through to the clinic. The final session will assess the progress that is being made on some of the most exciting targets being focused on within drug discovery. The lessons which can be learned from the hard won experience of this work will be reviewed. In summary, the most exciting current research in emerging fields of drug discovery will be covered during the course of the meeting.

View Meeting Program

Scholarships/Awards

Scholarship / Award Information


Scholarship Deadline: (11:59 PM US Mountain Standard Time)
*All deadlines end at 11:59 PM US Mountain Standard Time
NOTE: Please use the button above to Apply for a Scholarship

Scholarships

Keystone Symposia is offering scholarships of up to 1,200 USD to Students and Postdoctoral fellows. These scholarships are to be used to help defray the expenses associated with conference attendance, including airfare (restrictions may apply based on funding source), ground transportation, lodging costs, and a portion of meeting registration. Receipts will be required to receive reimbursement.

Abstracts submitted for poster presentation will be used as the basis for awarding the scholarships. Scholarship recipients will be selected based on the quality of science of the abstract and the relevance of the abstract to the conference topic. Only one application per abstract is accepted. Only one award per lab will be allocated.


Eligibility


To be eligible for a scholarship, you must be:

A graduate student or postdoctoral fellow currently enrolled in an academic institute at the start of the meeting for which you are applying. Note: a graduate student is defined as a student who is studying for a higher degree at an academic institution. A postdoctoral fellow is defined as an individual with a Ph.D., M.D., or DVM degree who is engaged in a temporary period of mentored research and/or scholarly training for the purpose of acquiring the professional skills needed to pursue their desired career path, and is within 6 years of these degrees.


Review Criteria


Criteria for Abstract Review:

  1. Relevance to the meeting topic
  2. Significance of the scientific question and results
  3. Style
    • Organization (e.g. the abstract has a clear beginning, middle and end)
    • Grammar and spelling
  4. Clarity of scientific presentations
    • Clear question or hypothesis
    • Sufficient background
    • The experimental approach and rationale for the approach are clear
    • The results are clearly presented
    • The interpretation and conclusions are reasonable and logical

Application Process


If you are eligible and wish to be considered for a scholarship, you should complete all of the following by the scholarship deadline for the meeting you wish to attend. It is recommended you begin these steps in advance of the deadline date to ensure completion.

Click here to start a scholarship application.

  See the Scholarship FAQ's

Underrepresented Trainee Scholarships are also available...
Please Click Here for more information about Underrepresented Trainee Scholarship.

  See the Underrepresented Trainee Scholarship FAQ's


If you have any questions, please contact scholarships@keystonesymposia.org.